EFPIA Newsletter 03 October 2019

Blogs     03 October 2019 Time is life From a societal perspective, the new wave of personalised medicines and cell and gene therapies offer real hope to patients... Read more →         03 October 2019 Protecting European citizens against vaccine–preventable diseases Vaccination certainly constitutes one of the most cost-effective health interventions existing today, preventing 2-3... Read more →

Videos - Oncology Data Summit

	Roberto Viola, Director General, DG CONNECT, European Commission		Nathalie Moll, Director General, EFPIA

Events     05 NOV 2019   Connecting Healthcare Debate Residence Palace, Rue de la Loi 175, 1000 Brussels Making connections can advance patient care and support the European economy at a time of significant change and challenge... Learn more →       14 OCT 2019   DIA MERC 2019 New Cairo, Egypt The collaborative platform for connecting Regulatory experts in the Middle East Learn more →

	31 OCT 2019			LifeTime meets industry Basel, Switzerland LifeTime is developing a Roadmap that will show the path on how technology developments will be combined with disease... Learn more →

	27 NOV 2019			Regenerative Medicine: Scientific Advances and Regulatory Framework in Europe Brussels The aim of this workshop is to provide a comprehensive overview on scientific advances, ongoing clinical trials, regulatory... Learn more →

We published Enabling self-efficacy through digital technologies and innovative therapies 01 October 2019 (Publications) Patients have the tools to measure and record data and, increasingly, have access to innovative technologies and therapies... Read more →

What we are reading Why transparency in drug pricing is more complicated than it seems 01 October 2019  (World Economic Forum) Read more → Official kick-off of the IMI2 JU 'Immune-Image’ project 01 October 2019  (immune-image.eu) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe